Cargando…
E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitry
Resistance to anti-neoplastic agents is the major cause of therapy failure, leading to disease recurrence and metastasis. E2F1 is a strong inducer of apoptosis in response to DNA damage through its capacity to activate p53/p73 death pathways. Recent evidence, however, showed that E2F1, which is aber...
Autores principales: | Alla, Vijay, Kowtharapu, Bhavani S., Engelmann, David, Emmrich, Stephan, Schmitz, Ulf, Steder, Marc, Pützer, Brigitte M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442917/ https://www.ncbi.nlm.nih.gov/pubmed/22871739 http://dx.doi.org/10.4161/cc.21476 |
Ejemplares similares
-
DNp73: oncotarget in invasion and metastasis
por: Pützer, Brigitte M.
Publicado: (2013) -
TAp73β and DNp73β activate the expression of the pro-survival caspase-2(S)
por: Toh, Wen Hong, et al.
Publicado: (2008) -
Hypoxia-induced DNp73 stabilization regulates Vegf-A expression and tumor angiogenesis similar to TAp73
por: Dulloo, Iqbal, et al.
Publicado: (2015) -
DNp73 improves generation efficiency of human induced pluripotent stem cells
por: Lin, Yi, et al.
Publicado: (2012) -
Image-Based Network Analysis of DNp73 Expression by Immunohistochemistry in Rectal Cancer Patients
por: Pham, Tuan D., et al.
Publicado: (2020)